alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT
      32.2


CERTIFICATION
      PURSUANT TO 18 U.S.C. SECTION 1350,


AS
      ADOPTED PURSUANT TO SECTION 906 OF THE


SARBANES-OXLEY ACT OF 2002





In 
      connection  with the quarterly report of Avitar,  Inc. (the 
"Company") on Form10-QSB/A for the period ending March 31, 2007 as filed with
      the Securities and Exchange  Commission on the date hereof (the 
"Report"),  I, Jay C. Leatherman,  Jr., Chief Financial 
Officer of the Company  certify,  pursuant to 18 U.S.C. Section
      1350, as adopted pursuant to Section 906 of the  Sarbanes-Oxley Act of
      2002, to my knowledge,


that:





(1) The Report fully  complies  with the  requirements  of
      Section 13(a) or15(d) of the Securities Exchange Act of 1934; and





(2)  The  information  contained  in the  Report 
fairly  presents,  in all material  respects,  the 
financial  condition  and results of operations of the Company.





Date:
      May
      15, 2007





/s/
      Jay C. Leatherman, Jr.


-------------------------


Jay
      C.
      Leatherman, Jr.


Chief
      Financial Officer (Principal Financial


and
      Accounting Officer), Secretary
**EXHIBIT 32.1** **CERTIFICATION    OF PRINCIPAL EXECUTIVE OFFICER**     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002     I, Keith A. Meister, Principal Executive Officer of American    Property Investors, Inc., the General Partner of American Real    Estate Partners, L.P. (the “Registrant”), certify that    to the best of my knowledge, based upon a review of the American    Real Estate Partners, L.P., quarterly report on    Form 10-Q    for the period ended June 30, 2006 of the Registrant (the    “Report”):     (1) The Report fully complies with the requirements of    Section 13(a) or 15(d) of the Securities Exchange Act of    1934, as amended; and     (2) The information contained in the Report fairly    presents, in all material respects, the financial condition and    results of operations of the Registrant. /s/  KEITH    A. MEISTER    Keith A. Meister    Principal Executive Officer and    Vice Chairman of the Board of    American Property Investors, Inc.,    the General Partner of    American Real Estate Partners, L.P.     Date: August 9, 2006
EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the quarter ended June 30, 2009 of Crimson Exploration Inc. (the “Issuer”). The undersigned hereby certifies that the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the            Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 

 

| Date:

  | August 12, 2009

                |   |
|---------------|---------------------------------------|--------|
|          | /s/ Allan D. Keel                     |   |
| Name:         | Allan D. Keel                         |   |
| Title:        | President and Chief Executive Officer |   |
|          |                                  |   |
|          |                                  |   |

 

A signed original of this written statement required by Section 906 has been provided to the Issuer and will be furnished to the Securities and Exchange Commission, or its staff, upon request.
<PAGE>


EXHIBIT 32 (b)

     CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Northland Cable Properties Seven
Limited Partnership (the "Partnership") on Form 10-Q for the period ended June
30, 2003 as filed with the Securities and Exchange Commission on the date hereof
(the "Form 10-Q"), I, Gary Jones, President of Northland Communications
Corporation, the General Partner, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that;

      (1)   The Form 10-Q fully complies with the requirements of Section 13 (a)
            or (15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or
            78(d)); and

      (2)   The information contained in the Form 10-Q fairly presents in all
            material respects, the financial condition and results of operations
            of the Partnership.

DATE: 8-13-03

/s/  GARY S. JONES
     --------------------------------
    Gary S. Jones
    President



A signed original of this written statement required by Section 906 has been
provided to Northland Cable Properties Seven Limited Partnership and will be
retained by Northland Cable Properties Seven Limited Partnership and furnished
to the Securities and Exchange Commission or its staff upon request.
Exhhibit 24.1

                                POWER OF ATTORNEY

      Each Director of PSEG Energy Holdings Inc. whose  signature  appears below
hereby  appoints  Derek  M.  DiRisio,  the  agent  for  service  named  in  this
Registration Statement, and James T. Foran, Esq. as attorney-in-fact, to execute
in the name of each such  person and to file with the  Securities  and  Exchange
Commission this  Registration  Statement and any and all  amendments,  including
post-effective amendments to this Registration Statement.

           Signature                         Title                    Date
           ---------                         ----                     ----


     /s/ ROBERT E. BUSCH                    Director          September 28, 2001
-----------------------------
        Robert E. Busch

       /S/ FRANK CASSIDY                    Director          September 28, 2001
-----------------------------
         Frank Cassidy

 /s/ ROBERT J. DOUGHERTY, JR.               Director          September 28, 2001
-----------------------------
   Robert J. Dougherty, Jr.

     /s/ E. JAMES FERLAND                   Director          September 28, 2001
-----------------------------
       E. James Ferland

     /s/ Thomas M. O'Flynn                  Director          September 28, 2001
-----------------------------
       Thomas M. O'Flynn

     /s/ R. EDWIN SELOVER                   Director          September 28, 2001
-----------------------------
       R. Edwin Selover
**OMB Support Statement Study**  **of Enhanced College Advising in Upward Bound**

**Abt Associates Inc. Appendix**  **F .**  **Non -**  **Disclosure Agreement**  ▌ **pg F**  **- 1**  

# Ap **pendix F**  **. Data User Non**  **- D**  **isclosure Ag**  **reement OMB Support Statement**  **Study of Enhanced College Advising in Upward Bound** 

**Abt Associates Inc. Appendix**  **F .**  **Non -**  **Disclosure Agreement**  ▌ **pg F**  **- 2**  

### I understand that, during the performance of the Study of Enhanced College Advising in Upward Bound, I may be given access to information of a confidential, proprietary, sensitive, or private nature. I agree that I shall only use this information to carry out my work and will follow the required procedures to protect the information from unauthorized release or disclosure. I further acknowledge that, while this information is in my possession, I shall be responsible to protect it from unauthorized disclosure and to restrict access to those who have a bona fide requirement for such access. I affirm that I have received a written and/or verbal briefing/training by my company concerning my responsibilities under this Agreement. I understand that violation of this Agreement may be cause for dismissal without notice. Printed Name: ________________________

_______________ Signature: ___________________________________________ Date: _______________________________________________
<PAGE>   1
                                                                    EXHIBIT 23.1


INDEPENDENT AUDITORS' CONSENT


We consent to the incorporation by reference in this Registration Statement of
Fred Meyer, Inc. on Form S-4 of our report dated March 12, 1997, appearing in
the Annual Report on Form 10-K of Fred Meyer, Inc., as amended by Form 10-K/A,
for the fiscal year ended February 1, 1997 and to the reference to us under the
headings "Fred Meyer Selected Historical Financial and Other Data" and "Experts"
in the Prospectus, which is part of this Registration Statement.



/s/ DELOITTE & TOUCHE LLP

DELOITTE & TOUCHE LLP

Portland, Oregon
January 23, 1998
Editorial Note on Part 172
Editorial Note: Nomenclature changes to part 172 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; 70 FR 72074, Dec. 1, 2005; and 81 FR 49896, July 29, 2016.

§ 172.340 Fish protein isolate. ( a ) The food additive fish protein isolate may be safely used as a food supplement in accordance with the following prescribed conditions: ( 1 ) The additive shall consist principally of dried fish protein prepared from the edible portions of fish after removal of the heads, fins, tails, bones, scales, viscera, and intestinal contents.
( 2 ) The additive shall be derived only from species of bony fish that are generally recognized by qualified scientists as safe for human consumption and that can be processed as prescribed to meet the required specifications.
( 3 ) Only wholesome fresh fish otherwise suitable for human consumption may be used. The fish shall be handled expeditiously under sanitary conditions. These conditions shall be in accordance with recognized good manufacturing practice for fish to be used as human food.
( 4 ) The additive shall be prepared by extraction with hexane and food-grade ethanol to remove fat and moisture. Solvent residues shall be reduced by drying.
( b ) The food additive meets the following specifications: (Where methods of determination are specified, they are Association of Official Analytical Chemists Methods, 13th ed., 1980, which are incorporated by reference).[1] ( 1 ) Protein content, as N × 6.25, shall not be less than 90 percent by weight of the final product, as determined by the method described in section 2.057, Improved Kjeldahl Method for Nitrate-Free Samples (20)—Official Final Action.
( 2 ) Moisture content shall not be more than 10 percent by weight of the final product, as determined by the method described in section 24.003, Air Drying (1)—Official First Action.
( 3 ) Fat content shall not be more than 0.5 percent by weight of the final product, as determined by the method described in section 24.005, Crude Fat or Ether Extract—Official Final Action.
( 4 ) Solvent residues in the final product shall not be more than 5 parts per million of hexane and 3.5 percent ethanol by weight.
[46 FR 38072, July 24, 1981, as amended at 47 FR 53344, Nov. 26, 1982; 54 FR 24897, June 12, 1989] Footnotes -
172.340
[1] Copies are available from: AOAC INTERNATIONAL, 481 North Frederick Ave., suite 500, Gaithersburg, MD 20877, or examined at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
I 

118TH CONGRESS 

2D SESSION H. R. 7494 

To amend the Securities Exchange Act of 1934 to prohibit exchanges from 

effecting transactions in securities issued by natural asset companies, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 29, 2024 

Mr. GREEN of Tennessee (for himself, Ms. HAGEMAN, Mr. BURCHETT, Mr. 

LAMBORN, Mr. CLOUD, Mr. OGLES, Mrs. MILLER of Illinois, Mr. ESTES, 

Mr. NORMAN, Mr. BANKS, Mr. SESSIONS, Mr. BISHOP of North Carolina, 

Mr. BOST, Mr. EDWARDS, Mr. DONALDS, Mr. FULCHER, Mr. SELF, Mr. 

CURTIS, Mr. DAVIDSON, Mr. ROSENDALE, Mr. NEWHOUSE, Mrs. 

FISCHBACH, Mr. MOONEY, Mr. MOOLENAAR, Mr. HIGGINS of Louisiana, 

Mr. ZINKE, Ms. BOEBERT, and Mr. STAUBER) introduced the following 

bill; which was referred to the Committee on Financial Services 

A BILL 

To amend the Securities Exchange Act of 1934 to prohibit 

exchanges from effecting transactions in securities issued 

by natural asset companies, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Protect America’s 

5 Lands Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7494 IH

1 SEC. 2. PROHIBITION WITH RESPECT TO EFFECTING 

2 TRANSACTIONS IN SECURITIES ISSUED BY 

3 NATURAL ASSET COMPANIES. 

4 Section 6 of the Securities Exchange Act of 1934 (15 

5 U.S.C. 78f) is amended by adding at the end the following: 

6 ‘‘(m) PROHIBITION WITH RESPECT TO EFFECTING

7 TRANSACTIONS IN SECURITIES ISSUED BY NATURAL

8 ASSET COMPANIES.— 

9 ‘‘(1) IN GENERAL.—It shall be unlawful for a 

10 national securities exchange registered under sub11 section (b) to effect a transaction in a security 

12 issued by a natural asset company. 

13 ‘‘(2) NATURAL ASSET COMPANY DEFINED.—In 

14 this subsection, the term ‘natural asset company’— 

15 ‘‘(A) means a company— 

16 ‘‘(i) that holds the rights to the eco17 logical performance (including value from 

18 natural assets and the production of eco19 system services) of a defined land area and 

20 has the authority to manage such area for 

21 conservation, restoration, or sustainable 

22 management; and 

23 ‘‘(ii) the primary purpose of which, 

24 with respect to such defined land area, is 

25 to— 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7494 IH

1 ‘‘(I) manage, maintain, restore, 

2 and grow the value of natural assets 

3 and the production of ecosystem serv4 ices in the area; or 

5 ‘‘(II) carry out activities that do 

6 not cause any material adverse impact 

7 on the condition of the natural assets 

8 in the area and replenish the natural 

9 resources used in the area; and 

10 ‘‘(B) includes any company that controls, 

11 is controlled by, or is under common control 

12 with another company described in subpara13 graph (A)’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 04-10157 Conference Calendar

GEORGE D. FARQUHAR, Petitioner-Appellant,

versus K.J. WENDT, Warden, Respondent-Appellee.

-------------------- Appeal from the United States District Court for the Northern District of Texas USDC No. 3:03-CV-1873-L

-------------------- Before BARKSDALE, DeMOSS, and CLEMENT, Circuit Judges.
PER CURIAM: * George D. Farquhar, federal prisoner # 28074-077, appeals the district court’s denial of his 28 U.S.C. § 2241 petition challenging his conviction for mail fraud. He argues that he is entitled to proceed pursuant to § 2241 because the 28 U.S.C. § 2255 remedy is inadequate given that his claims could not be raised in a successive § 2255 motion and, further, because Neder v. United States , 527 U.S. 1 (1999) establishes that he was convicted of a nonexistent offense. United States Court of Appeals Fifth Circuit 

## F I L E D June 23, 2004 Charles R. Fulbruge III ClerkNo. 04-10157 -2- A prior unsuccessful § 2255 motion, or the inability to meet the requirements for filing a successive § 2255 motion, does not make the § 2255 remedy inadequate, however. See Tolliver v. Dobre , 211 F.3d 876, 878 (5th Cir. 2000). Additionally, Farquhar cannot show that his claims were foreclosed at the time of his § 2255 motion because Neder was decided before that filing. See Reyes-Requena v. United States , 243 F.3d 893, 903-04 (5th Cir. 2001); Neder , 527 U.S. at 1. Farquhar therefore has not shown the § 2255 remedy inadequate, and he cannot proceed pursuant to § 2241.
AFFIRMED.
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM THE
QUARTERLY  REPORT 10-Q AND IS  QUALIFIED  IN ITS  ENTIRETY BY  REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CIK>  0000813807                       
<NAME>  COURTYARD BY MARRIOTT LIMITED PARTNERSHIP
<MULTIPLIER>  1,000
<CURRENCY>    U.S. DOLLAR
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1998
<PERIOD-START>                                 JAN-01-1998
<PERIOD-END>                                   JUN-19-1998
<EXCHANGE-RATE>                                1.00
<CASH>                                         8,289
<SECURITIES>                                   0
<RECEIVABLES>                                  2,659
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               18,976
<PP&E>                                         540,975
<DEPRECIATION>                                 (235,524)
<TOTAL-ASSETS>                                 335,375
<CURRENT-LIABILITIES>                          40,747
<BONDS>                                        316,801
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       0
<OTHER-SE>                                     (22,173)
<TOTAL-LIABILITY-AND-EQUITY>                   335,375
<SALES>                                        0
<TOTAL-REVENUES>                               50,048
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               25,888
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             12,328
<INCOME-PRETAX>                                11,832
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   11,832
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
        


</TABLE>
Exhibit 32.2  Certification of CFO

CERTIFICATIONS

I, Robert T. Malasek, Chief Financial Officer, certify that:

1.  I have reviewed this annual report on Form 10-KSB-A of Naturewell,
Incorporated;

2.  Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3.  Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this annual report;

4.  The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

     a)  designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;

     b)  evaluated the effectiveness of the registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing date of this
annual report (the "Evaluation Date"); and

     c)  presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures based on our evaluation
as of the Evaluation Date;

5.  The registrant's other certifying officers and I have disclosed, based on
our most recent evaluation, to the registrant's auditors and the audit
committee of registrant's board of directors (or persons performing the
equivalent function):

     a)  all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to record,
process, summarize and report financial data and have identified for the
registrant's auditors any material weaknesses in internal controls; and

     b)  any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls;
and

6.  The registrant's other certifying officers and I have indicated in this
annual report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date:  October 20, 2003                /s/ Robert T. Malasek
                                       ---------------------
                                           Robert T. Malasek
                                           Chief Financial Officer
§ 500.84 Conditions for approval of the sponsored compound. ( a ) On the basis of the results of the chronic bioassays and other information, FDA will determine whether any of the substances tested are carcinogenic.
( b ) If FDA concludes that the results of the bioassays do not establish carcinogenicity, then FDA will not subject the sponsored compound to the remainder of the requirements of this subpart.
( c ) For each sponsored compound that FDA decides should be regulated as a carcinogen, FDA will either analyze the data from the bioassays using a statistical extrapolation procedure as outlined in paragraph (c)(1) of this section or evaluate an alternate procedure proposed by the sponsor as provided in § 500.90. In either case, paragraphs (c)(2) and (3) of this section apply. ( 1 ) For each substance tested in separate bioassays, FDA will calculate the concentration of the residue of carcinogenic concern that corresponds to a maximum lifetime risk to the test animal of 1 in 1 million. FDA will designate the lowest value obtained as So. Because the total diet is not derived from food-producing animals, FDA will make corrections for food intake. FDA will designate as Sm the concentration of residue in a specific edible tissue corresponding to a maximum lifetime risk of cancer in test animals of 1 in 1 million.
( 2 ) From the appropriate residue chemistry data FDA will calculate the Rm as described in § 500.86(c). The sponsor must provide a regulatory method in accordance with § 500.88(b). FDA will calculate the LOD of the method from data submitted by the sponsor under § 500.88. The LOD must be less than or equal to Rm.
( 3 ) FDA will conclude that the provisions of this subpart are satisfied when no residue of the compound is detectable (that is, the marker residue is below the LOD) using the approved regulatory method under the conditions of use of the sponsored compound, including any required preslaughter withdrawal period or milk discard time.
[52 FR 49586, Dec. 31, 1987, as amended at 67 FR 78174, Dec. 23, 2002; 77 FR 50593, Aug. 22, 2012]
Exhibit 21.1  SUBSIDIARIES  1.  Wholly owned subsidiaries of First Mariner
Bancorp First
Mariner Bank FM
Appraisals, LLC Mariner
Capital Trust II Mariner
Capital Trust III Mariner
Capital Trust IV Mariner
Capital Trust V Mariner
Capital Trust VI Mariner
Capital Trust VII Mariner
Capital Trust VIII Mariner
Finance, LLC Hale
Canton, LLC Canton
Borrowing, LLC 2.  Wholly owned subsidiaries of First Mariner
Bank First
Mariner Mortgage Corporation (inactive) Compass
Properties, Inc. First
Mariner Financial Services, Inc. (inactive) FMB
Holdings, Inc. (inactive) Canton
Crossing II, LLC 3.  Wholly owned
subsidiary of Canton Crossing II, LLC Canton Crossing Borrower,
LLC 4.  Wholly owned subsidiaries of Mariner Finance,
LLC Mariner Finance of
Virginia, LLC Mariner
Finance Mortgage, LLC